Key result
Higher circulating ADGV is linked to increased risk of incident hypertriglyceridemia.
Why the study?
Are elevated circulating ADGV levels associated with an increased risk of prevalent and incident hypertriglyceridemia in adults?
Cohort (n=936)
Yes
Are elevated circulating ADGV levels associated with an increased risk of prevalent and incident hypertriglyceridemia in adults?
Elevated circulating ADGV is a novel, independent biomarker for prevalent and incident hypertriglyceridemia, with in vitro evidence suggesting it actively promotes hepatic lipogenesis.
Answers are grounded in this paper and cite their sources.
ADGV may flag hypertriglyceridemia risk; hypothesis-generating for causality and therapeutic targeting.
INTRODUCTION: Hypertriglyceridemia (HTG) is a crucial risk factor for cardiovascular disease, metabolic syndrome, and type 2 diabetes. However, its early detection remains challenging due to the dynamic fluctuations in plasma triglyceride levels and their limited utility in predicting long-term dyslipidemia. OBJECTIVES: This study aimed to elucidate the role of asymmetric dimethylguanidino valeric acid (ADGV) in HTG through integrated cohort analyses and mechanistic cellular experiments. METHODS: Circulating ADGV levels were quantified in a cross-sectional cohort from southern China (n = 588) and assessed its prospective association with incident HTG in an independent prospective cohort from northern China (n = 348, median follow-up: 1.8 years). Hepatocyte experiments were performed to examine biological plausibility and explore potential mechanisms linking ADGV to hepatic triglyceride metabolism. RESULTS: Elevated ADGV levels were significantly associated with increased risk of HTG and remained independently associated after adjustment for age, gender, BMI, eGFR, lifestyle factors, and liver function. Complementary in vitro studies in hepatocytes revealed that ADGV promoted triglyceride accumulation by stimulating de novo fatty acid synthesis, mediated through regulating the expression of key metabolic genes (ACC, CPT1α, and PGC1α). CONCLUSION: Higher circulating ADGV was independently associated with prevalent and incident hypertriglyceridemia across a cross-sectional cohort and an independent prospective cohort, and hepatocyte experiments support a contributory role of ADGV in hepatic lipogenesis.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) conducted a cohort in Hypertriglyceridemia (n=936). Elevated asymmetric dimethylguanidino valeric acid (ADGV) vs. Lower ADGV levels was evaluated on Incident hypertriglyceridemia. Higher circulating ADGV was independently associated with prevalent and incident hypertriglyceridemia across cross-sectional and prospective cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: